drugset / Trial / NCT06240390
Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain
Withdrawn
Universidad Europea de Canarias
RandomizedParallel-groupTriple-blindTreatment
Summary
the goal of this clinical trial is to compare in cancer patients: Is ultrasound-guided percutaneous neuromodulation useful for Anterior Knee Pain relief in cancer patients? Participants will receive treatments of ultrasound-guided percutaneous neuromodulation and pharmacological treatment Researchers will compare ultrasound-guided percutaneous neuromodulation versus pharmacological treatment to see if Anterior Knee Pain is reduced
Timeline
- Start
- 2024-05-01
- Primary completion
- 2024-08-30
- Completion
- 2025-02-01
Outcome
Outcome not reported
Stopped (Enrollment): “Study not initiated prior to enrollment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | — | — |
| Subject | Hydrocodone | Unknown | — | — |
| Subject | Hydromorphone | Other / unclassified | — | — |
| Subject | Methadone | Other / unclassified | — | — |
| Subject | Morphine | Other / unclassified | — | — |
| Subject | Oxycodone | Other / unclassified | — | — |
| Subject | Oxymorphone | Small molecule | — | — |
| Subject | Tapentadol | Small molecule | — | — |
| Subject | Tramadol | Other / unclassified | — | — |